Understanding survival and health outcomes of hemodialysis patients in Tanzania
Predicting Morbidity, Mortality, Short and Long-term Survival of End-stage Kidney Disease Patients on Hemodialysis in Central Tanzania; a Two-center Prospective Patient-registry Observational Study.
This study looks at the health and survival rates of patients on hemodialysis in Tanzania to understand their challenges and improve their care.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Sex | All |
| Sponsor | Benjamin Mkapa Hospital Academic / other |
| Locations | 1 site (Dodoma) |
| Trial ID | NCT03988491 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the morbidity and mortality rates of end-stage renal disease patients undergoing hemodialysis in Dodoma, Tanzania. It will identify predictors of mortality, common causes of infection and hospitalization, and analyze both short and long-term survival rates. The study will also establish a registry called the Tanzania Registry for Chronic Renal Failure to improve data collection and patient management. Conducted at two hemodialysis centers, it will provide valuable insights into the challenges faced by patients in a developing country.
Who should consider this trial
Good fit: Ideal candidates include individuals diagnosed with end-stage renal disease who are receiving maintenance hemodialysis at the participating centers.
Not a fit: Patients with acute kidney injury, those with chronic kidney disease stages other than stage 5, or individuals who have undergone kidney transplantation will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved patient outcomes and healthcare strategies for managing end-stage renal disease in Tanzania.
How similar studies have performed: While similar studies have been conducted in other regions, this specific approach in Tanzania is novel and aims to fill a significant gap in local healthcare data.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participants diagnosed with end-stage renal disease due to any etiology. * Participants initiated on maintenance dialysis. * Participants attending Benjamin Mkapa Hospital or UDOM health center. * Eligible participants consented to participate in the study. Exclusion Criteria: * Patients diagnosed with acute kidney injury. * Patients with CKD stage other than stage 5. * Patients underwent kidney transplantation. * Patients on dialysis other than hemodialysis.
Where this trial is running
Dodoma
- Benjamin Mkapa Hospital — Dodoma, Tanzania (Recruiting)
Study contacts
- Principal investigator: Joel D Swai, MMed — Benjamin Mkapa Hospital
- Study coordinator: Joel Swai, MMed
- Email: joel.swai@hotmail.com
- Phone: +8618508413470
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.